Maureen Moomjy
Reproductive Endocrinology · New York, NYNPI 1043399454
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations.
Across 111 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$455
- Ferring Pharmaceuticals Inc.$404
- Mayne Pharma Commercial LLC$231
- Millicent US Inc$222
- Novo Nordisk$210
- Astellas Pharma US Inc$187
- plus $921 from 16 others
What the payments were for
- Food & beverage$2,52396%
- Education$903%
- Gifts$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $455 |
| Ferring Pharmaceuticals Inc. | 17 | $404 |
| Mayne Pharma Commercial LLC | 16 | $231 |
| Millicent US Inc | 7 | $222 |
| Novo Nordisk | 7 | $210 |
| Astellas Pharma US Inc | 9 | $187 |
| EMD Serono, Inc. | 4 | $112 |
| Exeltis, USA Inc. | 5 | $108 |
| Avion Pharmaceuticals | 5 | $83 |
| Agile Therapeutics, Inc. | 4 | $73 |
| Hologic Sales And Service, LLC | 3 | $71 |
| Therapeuticsmd, Inc. | 3 | $68 |
| Vertical Pharmaceuticals, LLC | 3 | $67 |
| Pfizer | 3 | $67 |
| Coopersurgical, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $46 |
| Virtus Pharmaceuticals LLC | 2 | $43 |
| Ascend Therapeutics US, LLC | 2 | $35 |
| Merck | 2 | $33 |
| Evofem Biosciences, Inc. | 1 | $25 |
| Organon | 1 | $22 |
| Almatica Pharma LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,629 in reported general payments places this provider in the 80th percentile of 176 reproductive endocrinology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $1,802 |
| Estradiol (Twice Weekly)Estradiol | 15 | $876 |
Paid to pharmacies, not to this prescriber.
Other reproductive endocrinology in New York
- Samuel WilliamsNew York$73K
- Brian LevineNew York$68K
- Lucky SekhonNew York$50K
- Eric FormanNew York$36K
- Frederick LicciardiNew York$24K
- Bat-Sheva MaslowNew York$23K
- Glenn SchattmanNew York$19K
- Tia Jackson-BeyNew York$14K
- Paula BradyNew York$12K
- David SableNew York$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.